Daryl Freeman

TL;DR: A simple patient self-administered questionnaire can be used to identify patients with a high likelihood of having COPD, for whom spirometric testing is particularly important, and implementation of this questionnaire could enhance the efficiency and diagnostic accuracy of current screening efforts.

TL;DR: Opportunities to diagnose COPD at an earlier stage are being missed, and could be improved by case-finding in patients with lower respiratory tract symptoms and concordant long-term comorbidities.

TL;DR: FeNO measurement is an easy and non-invasive tool to use in clinical practice in patients with non-specific respiratory symptoms to predict response to inhaled corticosteroids, and further research is needed to examine its role in Patients with evidence of other airway diseases, such as chronic obstructive pulmonary disease.

TL;DR: Evidence suggests that early encouragement of smoking cessation, in conjunction with management of symptoms and treating activity limitation and exacerbations by appropriate non-pharmacologic and pharmacologic management at the earliest possible stage, could positively affect the impact and progression of the disease.

TL;DR: A short, symptom-based questionnaire identifies persons more likely to have COPD among persons with prior evidence of OLD as well as ability of individual questions in a multivariate framework to discriminate between persons with and without the study diagnosis of COPD.